Status:
UNKNOWN
Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases
Lead Sponsor:
Universidade Estadual de Londrina
Conditions:
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
Brief Summary
Social distancing during the COVID-19 pandemic could lead to clinical and functional deterioration of people living with chronic respiratory diseases (CRD). As they are considered risk group for COVID...
Eligibility Criteria
Inclusion
- Diagnosis of chronic obstructive pulmonary disease, asthma or interstitial lung disease;
- Absence of any severe and/or unstable cardiac disease;
- Absence of any orthopedic or neuromuscular condition that limits physical activity in daily life.
Exclusion
- Desire to leave the study at any time;
- Infection with SARS-CoV-2 during the study protocol.
Key Trial Info
Start Date :
October 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04693975
Start Date
October 16 2020
End Date
October 1 2022
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Reasearch in Respiratory Physiotherapy, State University of Londrina
Londrina, Paraná, Brazil, 86038-350